ASX-listed Aroa Biosurgery jumps on strong HY sales, forecast hike

Aroa Biosurgery

06/10/2021 01:13

** Shares of New Zealand-based Aroa Biosurgery  ARX.AX  rise
as much as 12.5% to A$1.215, post their biggest intraday pct
gain since July 2020 
    ** The soft tissue repair firm says it expects FY22 product
sales revenue to be at the upper end of its previous announced
NZ$30 mln to NZ$33 mln ($20.87 mln-$22.95 mln) forecast range
 urn:newsml:reuters.com:*:nASX5mMGqS
    ** Says prelim sales revenue for the first half of FY22 rose
108% to NZ$17 mln  
    ** Stock hits highest level since July 23 and is on track
for a second consecutive session of gain
    ** About 1.7 mln shares change hands, compared with the
30-day average of nearly 391,900 shares 
    ** Stock down ~6.1% this year, as of last close 

($1 = 1.4378 New Zealand dollars)

 (Reporting by Tejaswi Marthi in Bengaluru)
 ((tejaswi.marthi@thomsonreuters.com))